Sanofi (SNY) Non-Current Receivables (2018 - 2024)
Historic Non-Current Receivables for Sanofi (SNY) over the last 8 years, with Q3 2025 value amounting to $1.9 billion.
- Sanofi's Non-Current Receivables changed N/A to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year change of. This contributed to the annual value of $1.6 billion for FY2024, which is 69449.89% up from last year.
- Latest data reveals that Sanofi reported Non-Current Receivables of $1.9 billion as of Q3 2025.
- Sanofi's Non-Current Receivables' 5-year high stood at $1.9 billion during Q3 2025, with a 5-year trough of $138.9 million in Q2 2024.
- Over the past 5 years, Sanofi's median Non-Current Receivables value was $246.9 million (recorded in 2022), while the average stood at $655.7 million.
- Examining YoY changes over the last 5 years, Sanofi's Non-Current Receivables showed a top increase of 69876.53% in 2024 and a maximum decrease of 4684.41% in 2024.
- Sanofi's Non-Current Receivables (Quarter) stood at $200.2 million in 2021, then rose by 23.33% to $246.9 million in 2022, then dropped by 18.07% to $202.3 million in 2023, then soared by 698.77% to $1.6 billion in 2024, then rose by 20.11% to $1.9 billion in 2025.
- Its Non-Current Receivables stands at $1.9 billion for Q3 2025, versus $612.4 million for Q2 2025 and $1.6 billion for Q1 2025.